Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Richard D. Francis

Market Cap

15.82 Billion USD

Sector

Healthcare

Website

https://www.tevapharm.com

Last Update

2/22/2024, 12:00:00 PM

Description

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally.

Read More

Overview

Value

15

Growth

20

Health

32

Management

0

Analyst Opinion

77

Total

36

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Liked by analysts
  • Low preportion of income is paid as dividend

Risk Factors

  • Overvalued on cashflow basis
  • Has a high level of debt
  • Altman-Z score suggests a risk of bankruptcy
  • Disliked by Twitter users
  • Poor earnings and cashflow growth
  • Dividend could be at risk

Market Peers

TEVA

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

N/A

Revenue Growth (5 Year Average)

N/A

Ratings Consensus

Buy

Share Buybacks

N/A

Dividend Yeild (TTM)

0.00%

Valuation

Value Score

15

  • Free-cashflow-yeild of 5.50% is better than the market average (4.7%)
  • Estimated intrinsic-value of N/A is lower than current price ( 14.11 USD)
  • Margin-of-safety of N/A is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 9.4 USD

Current Price: 13.7 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

5.50%

PE/Earnings Growth

N/A

Price/Book

1.88x

Growth

Growth Score

20

  • Revenue growth has improved this yeara
  • Earnings growth has improved this year
  • 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
  • 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
  • 5 Year Average Free Cashflow growth of N/A is lower than the market average (12.35%)
  • Free Cashflow growth has slowed this year

Revenue Growth

N/A

Earnings Growth

N/A

Cashflow Growth

N/A

Health

Health Score

32

  • Assets cover liabilities
  • Altman-Z score suggests a risk of bankruptcy
  • Has a high level of debt
  • High financial leverage and base interest rate exposure
  • Requires debt for normal operation to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

0.43

Piostroski Score

5.00

Debt/Equity

2.28x

Current Assets/Liabilities

1.14x

Free Cashflow/Total Debt

0.01x

Debt/Capital

1.87x

Dividend

Secure Dividend Score

0

  • Long term dividend payout ratio of 0.00% is considered good
  • Payout ratio (TTM) of 0.00% is lower than the average (40%)
  • Dividends have shown growth over the last 5 years
  • Spending a lower percentage of their income on dividends than last 5 years
  • Dividend yeild of 0.00% is less than the market average (1.85%)
  • Very unsafe

Dividend Yeild

0.00%

Dividend Growth

N/A

Payout Ratio (Earnings)

0.00%

Payout Ratio (Cashflow)

0.00%

Management

Management Score

0

  • Return-on-capital-employed of 7.12% is lower than the market average (10%)
  • Return-on-equity of 4.14% is lower than the market average (15%)

Average Buybacks/Dilution

N/A

Recent Buybacks/Dilution

1.72%

5 Year Price Volitility

11.06%

Return On Assets

0.89%

Return On Capital Employed

7.12%

Return On Equity

4.14%

Return On Free Cashflow

N/A

Return On Investments

N/A

Social Sentiment

Social Sentiment Score

0

Twitter Sentiment

N/A

Stocktwits Sentiment

N/A

Analysts

Analyst Opinion

77

  • Ratings consensus is Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Teva Pharmaceutical Industries Limited

Currency

USD

Beta

1.187158

Vol Avg

13318654

Ceo

Mr. Richard D. Francis

Cik

0000818686

Cusip

881624209

Exchange

New York Stock Exchange

Full Time Employees

34004

Industry

Drug Manufacturers—Specialty & Generic

Sector

Healthcare

Ipo Date

1982-02-16

Address

124 Dvora Hanevi’a Street

City

Tel Aviv

State

Country

IL

Zip

6944020

Phone

972 3 914 8213

Analysis Last Updated

2/22/2024, 12:00:00 PM

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies